Join the DDA or

DHSC lifts validation protocol for 150mcg AAIs

EpiPen prescription protocol remains in place

November 30th 2018

Tagged: Clinical guidance news Dispensary guidance news

By Ailsa Colquhoun

From Thursday 29th November, adrenaline 150microgram auto-injectors are no longer be subject to additional validation processes.

The Department of Health and Social Care (DHSC) has stated that stock levels are now at a level where the validation protocol is no longer required.*

Dispensers are now permitted to dispense the total number of adrenaline 150microgram auto-injectors prescribed to each patient. However, whilst stock filters through the supply chain, some wholesalers may still apply a restriction to ordering levels.

* EpiPen products were subject to prescription validation prior to the protocol introduced October and this will continue as before.

For all the latest news of the 2018 DDA annual conference...

Learn more